BioHarvest Sciences Inc logo

BioHarvest Sciences Inc

FRA:8MV (Canada)  
€ 0.16 (0%) May 22
At Loss
Market Cap:
€ 99.00M ($ 107.22M)
Enterprise V:
€ 114.65M ($ 124.17M)
Volume:
-
Avg Vol (2M):
634.00
Also Trade In:

Business Description

Description
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
Name Current Vs Industry Vs History
Cash-To-Debt 0.24
Equity-to-Asset -0.99
Debt-to-Equity -1.5
Debt-to-EBITDA -2.97
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -8.45
Distress
Grey
Safe
Beneish M-Score -3.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 66.93
9-Day RSI 56.17
14-Day RSI 52.48
6-1 Month Momentum % 69.31
12-1 Month Momentum % 22.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.34
Quick Ratio 0.25
Cash Ratio 0.2
Days Inventory 131.7
Days Sales Outstanding 23.31
Days Payable 109.64

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.2
Shareholder Yield % -7.01

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 45.58
Operating Margin % -71.64
Net Margin % -97.5
FCF Margin % -53.36
ROA % -88.94
ROIC % -39.85
ROC (Joel Greenblatt) % -146.49

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 9.63
EV-to-EBIT -15.93
EV-to-EBITDA -16.82
EV-to-Revenue 12.65
EV-to-FCF -24.02
Earnings Yield (Greenblatt) % -6.27
FCF Yield % -4.9

Financials

FRA:8MV's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BioHarvest Sciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 9.2
EPS (TTM) (€) -0.023
Beta 1.96
Volatility % 36.08
14-Day RSI 52.48
14-Day ATR (€) 0.004377
20-Day SMA (€) 0.1605
12-1 Month Momentum % 22.14
52-Week Range (€) 0.101 - 0.2
Shares Outstanding (Mil) 574.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioHarvest Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

BioHarvest Sciences Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

BioHarvest Sciences Inc Frequently Asked Questions

What is BioHarvest Sciences Inc(FRA:8MV)'s stock price today?
The current price of FRA:8MV is €0.16. The 52 week high of FRA:8MV is €0.20 and 52 week low is €0.10.
When is next earnings date of BioHarvest Sciences Inc(FRA:8MV)?
The next earnings date of BioHarvest Sciences Inc(FRA:8MV) is .
Does BioHarvest Sciences Inc(FRA:8MV) pay dividends? If so, how much?
BioHarvest Sciences Inc(FRA:8MV) does not pay dividend.

Press Release

Subject Date
No Press Release